1619931-27-9(3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-)
1619931-27-9 Basic informationMore
- Product Name:3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
- Synonyms: GB002 PK-10571 Seralutinib 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- Seralutinib (GB002) Seralutinib (PK-10571 (S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide PK 10571,Seralutinib,inhibit,arterial,PDGFR,PK10571,PK-10571,PAH,Pulmonary,hypertension,GB 002,GB-002,Inhibitor,Platelet-derived growth factor receptor
- CAS:1619931-27-9
- MF:C27H27N5O3
- MW:469.54
- EINECS:
- Mol File:1619931-27-9.mol
-
Recommend You Select Member Companies
- Company Name:Aladdin Scientific
- Tel:+1-+1(833)-552-7181
- Nationality:United States
- Products Intro:Product Name:Seralutinib (GB002)
CAS:1619931-27-9
Purity:98% Package:$137.9/5mg;$414.9/25mg;$1038.9/100mg;Bulk package Remarks:98% - CB Index:58
- Related Information:Catalog(57511)
- Company Name:TargetMol Chemicals Inc.
- Tel:+1-781-999-5354
- Nationality:United States
- Products Intro:Product Name:Seralutinib；GB002
CAS:1619931-27-9
Package:10 mg；100 mg；2 mg；200 mg；25 mg；5 mg；50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY - CB Index:58
- Related Information:Catalog(19973)